Variants

Name	Paper	Description of Comparison	Gene	RSID	Association	Disease Status	MAF	Statistical Odds Ratio	Statistical P-value
Horowitz_rs73064425	Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease	Meta analysis, External data	LZTFL1, CCR9, SLC6A20, FYCO1, CXCR6, XCR1, CCR1, CCR3	rs73064425	Positive	Severe	0.07	1.42	0.00000000007
Pairo-Castineira_rs73064425	Genetic mechanisms of critical illness in Covid-19	Critical COVID vs controls UKB	LZTFL1, FYCO1,CXCR6,CCR2,CCR3, SLC6A20	rs73064425	Positive	Critical	None	2.1	0.0000000000000000000000000000048
Horowitz_2_rs73064425	Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease	severe COVID-19 vs COVID-19negative or unknown	LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3	rs73064425	positive	Susceptibility	7.0	1.58	0.000000000000000002
Horowitz_2_rs73064425	Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease	COVID-19 severe vs not hospitalised	LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3	rs73064425	positive	Severe	None	1.59	0.00000000000000428

Papers

Paper
Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease
Genetic mechanisms of critical illness in Covid-19
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease